| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;110:948-954.)
© 2004 American Heart Association, Inc.
Original Articles |
From the Unit of Pharmacology and Therapeutics (C.D., S.M., P.G., J.L.B.) and Divisions of Cardiology (X.H.) and Cardiovascular Surgery (P.N.), Saint-Luc University Clinic and Université Catholique de Louvain, Brussels, Belgium.
Correspondence to Dr J.L. Balligand, Unit of Pharmacology and Therapeutics, Université Catholique de Louvain, FATH5349, avenue E. Mounier 53, B-1200, Brussels, Belgium. E-mail Balligand{at}mint.ucl.ac.be
Received June 16, 2003; de novo received December 26, 2003; revision received May 6, 2004; accepted May 10, 2004.
Background Coronary vessel tone is modulated in part by ß-adrenergic relaxation. However, the implication of specific ß-adrenoceptor subtypes and their downstream vasorelaxing mechanism(s) in human coronary resistance arteries is poorly defined. ß3-Adrenoceptors were recently shown to vasodilate animal vessels and are expressed in human hearts.
Methods and Results We examined the expression and functional role of ß3-adrenoceptors in human coronary microarteries and their coupling to vasodilating nitric oxide (NO) and/or hyperpolarization mechanisms. The expression of ß3-adrenoceptor mRNA and protein was demonstrated in extracts of human coronary microarteries. Immunohistochemical analysis revealed their exclusive localization in the endothelium, with no staining of vascular smooth muscle. In contractility experiments in which videomicroscopy was used, the nonspecific ß-agonist isoproterenol and the ß3-preferential agonist BRL37344 evoked an
50% relaxation of endothelin-1-preconstricted human coronary microarteries. Relaxations were blocked by the ß1/ß2/ß3-adrenoceptor antagonist bupranolol but were insensitive to the ß1/ß2-adrenoceptor antagonist nadolol, confirming a ß3-adrenoceptor-mediated pathway. Relaxation in response to BRL37344 was absent in human coronary microarteries devoid of functional endothelium. When human coronary microarteries were precontracted with KCl (thereby preventing vessel hyperpolarization), the relaxation to BRL37344 was reduced to 15.5% and totally abrogated by the NO synthase inhibitor L-
-nitroarginine, confirming the participation of a NO synthase-mediated relaxation. The NO synthase-independent relaxation was completely inhibited by the Ca2+-activated K+ channel inhibitors apamin and charybdotoxin, consistent with an additional endothelium-derived hyperpolarizing factor-like response. Accordingly, membrane potential recordings demonstrated vessel hyperpolarization in response to ß3-adrenoceptor stimulation.
Conclusions ß3-adrenoceptors are expressed in the endothelium of human coronary resistance arteries and mediate adrenergic vasodilatation through both NO and vessel hyperpolarization.
Key Words: receptors, adrenergic, beta endothelium-derived factors nitric oxide vasodilation
This article has been cited by other articles:
![]() |
X. F. Figueroa, I. Poblete, R. Fernandez, C. Pedemonte, V. Cortes, and J. P. Huidobro-Toro NO production and eNOS phosphorylation induced by epinephrine through the activation of {beta}-adrenoceptors Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H134 - H143. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rozec, M. Erfanian, K. Laurent, J.-N. Trochu, and C. Gauthier Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart. J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1532 - 1538. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Balligand beta(3)-Adrenoceptor stimulation on top of beta(1)-adrenoceptor blockade "Stop or Encore?". J. Am. Coll. Cardiol., April 28, 2009; 53(17): 1539 - 1542. [Full Text] [PDF] |
||||
![]() |
E. Barbato Role of adrenergic receptors in human coronary vasomotion Heart, April 1, 2009; 95(7): 603 - 608. [Full Text] [PDF] |
||||
![]() |
F. Frerart, P. Sonveaux, G. Rath, A. Smoos, A. Meqor, N. Charlier, B. F. Jordan, J. Saliez, A. Noel, C. Dessy, et al. The Acidic Tumor Microenvironment Promotes the Reconversion of Nitrite into Nitric Oxide: Towards a New and Safe Radiosensitizing Strategy Clin. Cancer Res., May 1, 2008; 14(9): 2768 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Saliez, C. Bouzin, G. Rath, P. Ghisdal, F. Desjardins, R. Rezzani, L.F. Rodella, J. Vriens, B. Nilius, O. Feron, et al. Role of Caveolar Compartmentation in Endothelium-Derived Hyperpolarizing Factor-Mediated Relaxation: Ca2+ Signals and Gap Junction Function Are Regulated by Caveolin in Endothelial Cells Circulation, February 26, 2008; 117(8): 1065 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kou and T. Michel Epinephrine Regulation of the Endothelial Nitric-oxide Synthase: ROLES OF RAC1 AND beta3-ADRENERGIC RECEPTORS IN ENDOTHELIAL NO SIGNALING J. Biol. Chem., November 9, 2007; 282(45): 32719 - 32729. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rouget, O. Barthez, F. Goirand, M.J. Leroy, M. Breuiller-Fouche, Z. Rakotoniaina, P. Guerard, E.J. Morcillo, C. Advenier, P. Sagot, et al. Stimulation of the ADRB3 Adrenergic Receptor Induces Relaxation of Human Placental Arteries: Influence of Preeclampsia Biol Reprod, January 1, 2006; 74(1): 209 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dessy, J. Saliez, P. Ghisdal, G. Daneau, I. I. Lobysheva, F. Frerart, C. Belge, K. Jnaoui, P. Noirhomme, O. Feron, et al. Endothelial {beta}3-Adrenoreceptors Mediate Nitric Oxide-Dependent Vasorelaxation of Coronary Microvessels in Response to the Third-Generation {beta}-Blocker Nebivolol Circulation, August 23, 2005; 112(8): 1198 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rozec, S. Serpillon, G. Toumaniantz, C. Seze, Y. Rautureau, O. Baron, J. Noireaud, and C. Gauthier Characterization of Beta3-Adrenoceptors in Human Internal Mammary Artery and Putative Involvement in Coronary Artery Bypass Management J. Am. Coll. Cardiol., July 19, 2005; 46(2): 351 - 359. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |